Tirzepatide Weight Loss

Tirzepatide is a dual GIP and GLP-1 receptor agonist that supports metabolic signaling beyond appetite control alone. When clinically appropriate, it can help patients who feel stuck despite doing many of the right things.

As a dual GIP and GLP-1 receptor agonist, tirzepatide provides metabolic support beyond appetite control and may help individuals who need more than diet and exercise alone.

Many people feel frustrated because they’re eating less, exercising more, and still struggling to lose weight. In many cases, the issue is not effort—it’s metabolism.

At Revive Wellness & Beauty in Powell, Ohio, tirzepatide is used as part of a structured, provider-led medical weight loss program, not a one-size-fits-all protocol and not a rapid, automated escalation model.

Your care begins with a comprehensive medical consultation to determine whether tirzepatide is clinically appropriate based on your history, prior weight- loss response, goals, and metabolic profile.

Because of its dual mechanism, tirzepatide requires thoughtful titration. We do not follow automated escalation schedules. Dosing is adjusted based on response, tolerance, and progress — with safety and sustainability as priorities.

Tirzepatide is not intended to remain indefinitely at high doses. After active weight loss, we build a structured maintenance plan that may include tapering, lower maintenance dosing, oral GLP-1 or non-medication strategies to reduce the risk of weight regain.